News

LUMIER PHARMA LLC and F.Hoffmann-La Roche Ltd social project on the production of PEGFERON, PEG-interferon alpha-2a in Ukraine

Commenced in March, 2010 was the first stage of work on the mutual social project of the world’s leading manufacturer of pharmaceuticals, the F.Hoffmann-La Roche Ltd Company, and the domestic company LUMIER PHARMA LLC on the production of PEGFERON, PEG-interferon alpha-2a, injection solution in vials of 180 mcg/ 1 ml, which was registered in Ukraine in November, 2011. The successful implementation of the project will help improve the accessibility of medications and the quality of medicines, as well as optimize treatment results in patients with viral hepatitis diseases and HIV/AIDS with co-infection in Ukraine.

print friendly version